Showing results (151-160 of 220) with videos related to

Sort By:
Pageof 22
The European Respiratory Journal|July 9, 2011
Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradientsS J Scheidl, C Englisch, G Kovacs, et al.
Parkinsonism & Related Disorders|August 5, 2021
Serum neurofilament is associated with motor function, cognitive decline and subclinical cardiac damage in advanced Parkinson's disease (MARK-PD)Louisa Niemann, Susanne Lezius, Aleksandra Maceski, et al.
ACS Nano|March 6, 2025
Breakdown of Magic Numbers in Spherical ConfinementJunwei Wang, Jonathan Martín-González, Lukas J Römling, et al.
Retina (Philadelphia, Pa.)|June 2, 2025
EFFICIENCY OF AN INNOVATIVE TROCAR ADAPTER FOR FASTER SILICONE OIL INJECTION IN VITREORETINAL SURGERY: A Comparative Laboratory StudyPhilip Wakili, Karl T Boden, Clemens N Rudolph, et al.
Journal of Psychiatry & Neuroscience : JPN|January 27, 2015
Reduced activation in the ventral striatum during probabilistic decision-making in patients in an at-risk mental stateFranziska Rausch, Daniela Mier, Sarah Eifler, et al.
Schizophrenia Research|May 17, 2014
Reduced activation in ventral striatum and ventral tegmental area during probabilistic decision-making in schizophreniaFranziska Rausch, Daniela Mier, Sarah Eifler, et al.
Journal of Thoracic Disease|October 29, 2019
Unraveling the role of ectopic thymic tissue in patients undergoing thymectomy for myasthenia gravisFeng Li, Ya Tao, Gero Bauer, et al.
Psychiatry Research|December 23, 2014
Metamemory in schizophrenia: retrospective confidence ratings interact with neurocognitive deficitsSarah Eifler, Franziska Rausch, Frederike Schirmbeck, et al.
Early Intervention in Psychiatry|May 13, 2016
Early cognitive basic symptoms are accompanied by neurocognitive impairment in patients with an 'at-risk mental state' for psychosisSarah Eisenacher, Franziska Rausch, Fabian Ainser, et al.
Immunotargets and Therapy|July 16, 2025
Preclinical Evaluation of a B7-H3 Targeting Antibody Enhancing NK Cell-Mediated Cytotoxicity for Ovarian Cancer TreatmentIlona Hagelstein, Sven Mattern, Kevin Wang, et al.
Pageof 22